Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 91251-91300 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02403505
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating CEA Positive Rectal Cancer
PHASE1
Active, not recruiting
20 participants
Started: Dec 28, 2021 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT04731610
Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)
NA
Recruiting
314 participants
Started: Dec 28, 2021 · Completed: Dec 28, 2029
1 condition
1 sponsor
20 locations
NCT05164094
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
PHASE1/PHASE2
Active, not recruiting
867 participants
Started: Dec 28, 2021 · Completed: Oct 5, 2026
1 condition
1 sponsor
65 locations
NCT05147467
Study of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
PHASE2
Recruiting
75 participants
Started: Dec 28, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
11 locations
NCT04925479
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
PHASE1/PHASE2
Recruiting
44 participants
Started: Dec 27, 2021 · Completed: Nov 1, 2031
1 condition
1 sponsor
40 locations
NCT04676802
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
PHASE2
Recruiting
121 participants
Started: Dec 27, 2021 · Completed: Aug 31, 2027
2 conditions
1 sponsor
2 locations
NCT05188885
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
N/A
Recruiting
90,000 participants
Started: Dec 27, 2021 · Completed: Dec 27, 2028
1 condition
1 sponsor
8 locations
NCT05164653
Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)
PHASE4
Active, not recruiting
400 participants
Started: Dec 27, 2021 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT05262426
Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults
NA
Active, not recruiting
145 participants
Started: Dec 27, 2021 · Completed: Jul 31, 2026
1 condition
4 sponsors
3 locations
NCT05231005
Fourth BNT162b2 COVID-19 Vaccine Dose
PHASE4
Active, not recruiting
1,000 participants
Started: Dec 27, 2021 · Completed: Jun 26, 2024
1 condition
1 sponsor
1 location
NCT05160922
Crizotinib Continuation Clinical Study
PHASE4
Active, not recruiting
27 participants
Started: Dec 27, 2021 · Completed: Mar 21, 2028
3 conditions
1 sponsor
13 locations
NCT05180526
Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)
PHASE4
Active, not recruiting
60 participants
Started: Dec 27, 2021 · Completed: Dec 30, 2024
1 condition
1 sponsor
7 locations
NCT06363032
Elastography in Predicting Renal Outcome
N/A
Recruiting
500 participants
Started: Dec 27, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05418764
Effect of Validated Skills Simulation With the Miya Model
NA
Recruiting
70 participants
Started: Dec 27, 2021 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05215639
A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy in Switzerland and Austria Receiving Oral Venetoclax Tablets
N/A
Active, not recruiting
125 participants
Started: Dec 27, 2021 · Completed: Nov 30, 2025
1 condition
1 sponsor
19 locations
NCT05181033
Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor
PHASE2
Recruiting
120 participants
Started: Dec 27, 2021 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
NCT05026983
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
PHASE2
Recruiting
35 participants
Started: Dec 27, 2021 · Completed: Feb 2, 2027
3 conditions
1 sponsor
1 location
NCT04883671
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
NA
Recruiting
32 participants
Started: Dec 27, 2021 · Completed: Jun 1, 2030
2 conditions
3 sponsors
5 locations
NCT05773638
Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
N/A
Recruiting
100 participants
Started: Dec 26, 2021 · Completed: Dec 26, 2026
1 condition
1 sponsor
6 locations
NCT06279611
An Evaluation of LY007 Cell Injection for r/r B-NHL
PHASE1
Recruiting
18 participants
Started: Dec 25, 2021 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT06364852
An Evaluation of LY007 Cell Injection for r/r B-NHL
PHASE1
Recruiting
18 participants
Started: Dec 25, 2021 · Completed: May 31, 2026
1 condition
3 sponsors
1 location
NCT05762991
Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion
N/A
Recruiting
2,000 participants
Started: Dec 24, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05171166
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
PHASE2/PHASE3
Recruiting
156 participants
Started: Dec 24, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05175053
Early RRT in AKI After Cardiac Surgery
NA
Recruiting
202 participants
Started: Dec 24, 2021 · Completed: Sep 30, 2028
1 condition
2 sponsors
2 locations
NCT04733378
Impact of Surgical Timing on the Neurodevelopmental Prognosis of Newborns With Complex Congenital Heart Disease
NA
Recruiting
50 participants
Started: Dec 24, 2021 · Completed: Dec 24, 2025
1 condition
1 sponsor
1 location
NCT05170542
The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.
PHASE2
Recruiting
42 participants
Started: Dec 24, 2021 · Completed: Jan 24, 2026
1 condition
1 sponsor
1 location
NCT05665179
Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
NA
Recruiting
800 participants
Started: Dec 23, 2021 · Completed: Jul 31, 2025
6 conditions
2 sponsors
2 locations
NCT05013255
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
PHASE2
Recruiting
30 participants
Started: Dec 23, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05105971
Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China
PHASE1
Active, not recruiting
30 participants
Started: Dec 23, 2021 · Completed: Nov 14, 2024
1 condition
1 sponsor
1 location
NCT05803993
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation
NA
Recruiting
35 participants
Started: Dec 23, 2021 · Completed: Dec 23, 2025
1 condition
1 sponsor
1 location
NCT05146349
Minnesota RETAIN Impact Evaluation
NA
Recruiting
3,200 participants
Started: Dec 23, 2021 · Completed: Feb 28, 2026
1 condition
5 sponsors
1 location
NCT05257135
A Clinico-biological Database in Cachexia in Patients With Colon Cancer
NA
Recruiting
150 participants
Started: Dec 23, 2021 · Completed: May 31, 2029
1 condition
1 sponsor
1 location
NCT04886726
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
PHASE1
Recruiting
18 participants
Started: Dec 23, 2021 · Completed: Nov 30, 2027
1 condition
1 sponsor
1 location
NCT05803980
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
NA
Recruiting
35 participants
Started: Dec 23, 2021 · Completed: Dec 23, 2025
1 condition
1 sponsor
1 location
NCT05385887
Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial
NA
Recruiting
298 participants
Started: Dec 23, 2021 · Completed: Aug 1, 2025
3 conditions
2 sponsors
11 locations
NCT05174910
Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery
NA
Active, not recruiting
250 participants
Started: Dec 23, 2021 · Completed: Dec 31, 2024
1 condition
5 sponsors
13 locations
NCT04942067
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Recruiting
108 participants
Started: Dec 23, 2021 · Completed: Dec 1, 2024
2 conditions
1 sponsor
3 locations
NCT05103046
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
PHASE1
Recruiting
68 participants
Started: Dec 23, 2021 · Completed: Dec 15, 2025
1 condition
2 sponsors
5 locations
NCT05216016
Minnesota RETAIN Phase 2 (Sub-study)
NA
Active, not recruiting
5,200 participants
Started: Dec 23, 2021 · Completed: May 31, 2026
3 conditions
7 sponsors
1 location
NCT05147558
A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma
PHASE2
Active, not recruiting
40 participants
Started: Dec 23, 2021 · Completed: Dec 23, 2025
2 conditions
2 sponsors
7 locations
NCT05102279
Analysis of Urine Composition Saturation and Dietary Intervention in Subjects Without Urinary Calculi
NA
Active, not recruiting
10 participants
Started: Dec 23, 2021 · Completed: Dec 30, 2024
3 conditions
1 sponsor
1 location
NCT05108428
Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
EARLY_PHASE1
Active, not recruiting
20 participants
Started: Dec 23, 2021 · Completed: Oct 31, 2026
1 condition
3 sponsors
1 location
NCT06071195
All-in-One Prostate Cancer Staging with MRI
N/A
Recruiting
400 participants
Started: Dec 22, 2021 · Completed: Aug 22, 2026
1 condition
3 sponsors
3 locations
NCT05218668
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
PHASE2
Active, not recruiting
40 participants
Started: Dec 22, 2021 · Completed: Jan 31, 2029
1 condition
1 sponsor
12 locations
NCT05132166
A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease
PHASE2
Active, not recruiting
50 participants
Started: Dec 22, 2021 · Completed: Apr 26, 2026
1 condition
1 sponsor
1 location
NCT05626348
The Clinical Efficacy of Immunomodulators in RA Patients
PHASE4
Recruiting
400 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06059885
Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC
PHASE2
Recruiting
60 participants
Started: Dec 22, 2021 · Completed: Dec 20, 2025
1 condition
1 sponsor
1 location
NCT04631471
Regeneration in Cervical Degenerative Myelopathy
PHASE3
Recruiting
400 participants
Started: Dec 22, 2021 · Completed: Sep 1, 2026
2 conditions
1 sponsor
1 location
NCT05207098
A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy
N/A
Active, not recruiting
54 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
7 locations
NCT05071209
Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors
PHASE1/PHASE2
Active, not recruiting
31 participants
Started: Dec 22, 2021 · Completed: Nov 22, 2025
8 conditions
1 sponsor
29 locations
Previous
1
More pages
1823
1824
1825
1826
1827
1828
1829
More pages
2369
Next